Evaluation of BMS-986142, a reversible Bruton's tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2, randomised, double-blind, dose-ranging, placebo-controlled, adaptive design study
| Autor: | Conaghan, Philip G *, Nowak, Miroslawa, Du, Shuyan, Luo, Yi, Landis, Jessica, Pachai, Chahin, Fura, Aberra, Catlett, Ian M, Grasela, Dennis M, Østergaard, Mikkel |
|---|---|
| Zdroj: | In The Lancet Rheumatology May 2023 5(5):e263-e273 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|